Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon

MyoKardia Announces Presentations at American Heart Association Scientific Sessions 2015

MyoKardia, Inc., a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced presentations at the American Heart Association (AHA) Scientific Sessions 2015, being held November 7-11 in Orlando, Fla.

Thumbnail

DOJ investigation in ICD misuse continues

Although the Department of Justice (DOJ) announced on Oct. 30 that it had settled with 457 hospitals for allegedly improperly implanting implantable cardioverter defibrillators (ICDs), it said it will to continue to investigate hospitals and health systems that fail to comply with the ICD implantation rules.

IN.PACT Admiral Drug-Coated Balloon Cost-Effectiveness Study and Global Study Results of In-Stent Restenosis Population Highlighted in Late Breaking Clinical Trials at VIVA 2015

Medtronic plc (NYSE: MDT) adds to the robust data for its IN.PACT® Admiral® drug-coated balloon (DCB)  with the presentation of both its formal cost-effectiveness analysis from the U.S. cohort of the IN.PACT SFA Trial and clinical results from the in-stent restenosis cohort data from Medtronic's IN.PACT Global Study. 

Medtronic Unveils New Aortic and Peripheral Data from Two Late-Breaking Clinical Trials at VIVA 2015

Medtronic plc (NYSE: MDT) today announced new clinical data in interventional treatments for aortic and peripheral vascular diseases in a late-breaking trial session at Vascular Interventional Advances (VIVA) 2015.

Tryton Medical Files Pre-Market Approval Application with US FDA for Tryton Side Branch Stent

Tryton Medical, Inc., the leading developer of stents designed to treat coronary bifurcation lesions, today announced that it has filed the final module of its Pre-Market Approval (PMA) application with the U.S. Food and Drug Administration (FDA) for the Tryton Side Branch Stent.

Thumbnail

Stroke Imaging Breaks the Speed Barrier

Endovascular treatment has emerged as the best thing since intravenous tissue plasminogen activator (IV t-PA) for acute ischemic stroke after five recent studies showed positive outcomes. Stent retrievers starred in the trials, with imaging playing a critical supporting role. But in clinical practice, which neuroimaging method best identifies likely beneficiaries is up for debate.

Thumbnail

Technology Refresh: Integrating Cath Lab to CVIT

Sponsored by GE Healthcare

Growth seeded the need for a dedicated PCI program at Saratoga Hospital that went live in January along with a complete technology overhaul: cath lab, hemodynamic monitoring, echocardiography and a fully integrated cardiovascular information system. The PCI program, close to 100 interventions later, is now considered a jewel of the county and a model for other facilities considering a technology refresh.

Thumbnail

Robotics in the Cath Lab: Balancing Physician Safety with Cost Concerns

Once just a feature of science fiction, robotics is now an integral part of the current healthcare landscape. With the advent of robotic-assisted percutaneous coronary intervention (PCI), interventional cardiology may be poised to experience a tectonic shift.

Displaying 1665 - 1672 of 2645

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.